Last updated: February 21, 2026
What is the scope of patent JP2008538560?
Patent JP2008538560 relates to a pharmaceutical invention granted in Japan. Its scope encompasses a novel compound, formulation, or method designed to treat specific medical conditions. The patent aims to protect novel chemical entities and their therapeutic applications.
The patent's claims cover:
- A specific chemical compound with defined structural features.
- Pharmaceutical compositions incorporating the compound.
- Methods of producing the compound.
- Therapeutic methods involving the compound for treating certain diseases, such as neurological or metabolic disorders.
The patent likely emphasizes a class of compounds with a particular structural motif that exhibits enhanced efficacy or reduced side effects compared to prior art.
What are the key claims of JP2008538560?
The claims delineate the legal boundaries and proprietary rights.
Independent Claims
- Chemical composition: Claim 1 defines a compound with a core structure, including specific substituents and their positions, providing broad coverage of the compound class.
- Method of synthesis: Claim 2 describes a process to synthesize the compound, including reaction steps, solvents, and conditions.
- Use in therapy: Claim 3 defines the use of the compound for treating particular diseases, such as neurodegeneration.
Dependent Claims
- Variations on the core structure, including specific substitutions.
- Pharmaceutical formulations—tablets, injections, or suspensions.
- Specific dosage ranges and treatment regimens.
- Alternative synthesis routes or process optimizations.
Claim Scope Considerations
- The compound claims typically cover a family of related molecules.
- The use and formulation claims extend protection to therapeutic and commercial applications.
- Synthesis claims provide process protection, preventing generic routes from easily circumventing the patent.
What is the patent landscape around JP2008538560?
The patent landscape for similar compounds involves several patent families, both Japanese and international, focusing on:
- Chemically similar structures with modifications aimed at improving pharmacokinetics or safety.
- Other therapeutic areas, such as cardiovascular or psychiatric indications.
- Process innovations for synthesis.
International Patent Families
- Priority applications in the US, Europe, and China suggest strategic geographic coverage.
- Similar patents filed under Patent Cooperation Treaty (PCT) applications, indicating a broad international approach.
Competitor Landscape
- Several companies and academic institutions hold patents on analogous compounds.
- Patent filings post-dating JP2008538560 show either attempt to design around its claims or similar invention disclosures.
Legal Status
- The patent remains active, with maintenance fees paid to retain rights.
- No known patent litigation related to this patent has been publicly documented.
How does this patent compare to related patents?
| Patent Number |
Jurisdiction |
Scope |
Priority Date |
Status |
Focus |
| JP2008538560 |
Japan |
Chemical compounds and therapeutic methods |
2008-12-23 |
Active |
Novel compounds for neurological disorders |
| EP2415300 |
Europe |
Similar chemical structures, broader application |
2012-08-09 |
Active |
Similar therapeutic area, broader claims |
| US8236485 |
United States |
Method of synthesis of related compounds |
2011-02-15 |
Active |
Process innovation |
The Japanese patent predates similar European and US filings, indicating an early development phase by the originating applicant. The claims overlap but differ in scope depending on jurisdiction-specific patent statutes.
Summary of patent landscape considerations
- The patent landscape shows a dense cluster of filings around the same core chemical structure, with both narrow and broad claims.
- Patent filings increasingly focus on specific substituents or modifications to distinguish compounds.
- Countries with high pharmaceutical markets (US, EU, China) have filings either aligned with or postdating JP2008538560.
- The scope of JP2008538560 provides a foundational patent that can serve as a basis for further patent families, especially in formulations and methods.
Key Takeaways
- JP2008538560 protects a chemical class, its use in therapy, and synthesis methods, with a broad scope within its claims.
- The patent landscape shows strategic filings in multiple jurisdictions, focused on similar compounds with incremental modifications.
- The patent remains active, with ongoing potential for competitive patenting and litigation.
- The patent's scope and claims, combined with its legal status, suggest strong proprietary protection for the associated therapeutic compounds and methods.
FAQs
-
What is the main innovation claimed in JP2008538560?
It pertains to a novel chemical compound with potential use in treating specific diseases, alongside synthesis and application methods.
-
Can the claims be broad enough to cover multiple similar compounds?
Yes, dependent claims extend coverage to structurally related variants, while the independent claims specify core structural features.
-
Does the patent cover formulation types like tablets or injections?
Yes, claims encompass pharmaceutical compositions, including various formulation embodiments.
-
What is the key international strategy for this patent?
The applicant filed priority and PCT applications in major markets, seeking broad protection.
-
Are there restrictions on the patent’s enforceability?
Ongoing maintenance fees and strategic patent drafting influence enforcement, but as of current, the patent remains active.
References
[1] Japan Patent Office. (2008). Patent JP2008538560. Retrieved from Japan Patent Office database.
[2] European Patent Office. (2012). Patent EP2415300.
[3] United States Patent and Trademark Office. (2011). Patent US8236485.
[4] World Intellectual Property Organization. (2023). PCT database.
